Nguyen Thi Dung

4PUBLICATIONS
4CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersSolid tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 14, 2023
Sorafenib as first-line treatment for patients with primary hepatocellular carcinoma: an outcome evaluation.

Dung Thi Nguyen, Duong Hoang Nguyen, Van Thi Hong Nguyen

|Feb 02, 2023
One Patient With 4 Different Primary Cancers: A Case Report.

Dung Thi Nguyen, Lan Mai Nguyen, Thang Le Phan

Pageof 1